| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8285851 | Parkinsonism & Related Disorders | 2016 | 8 Pages |
Abstract
The serotonergic system is likely to be involved in the pathophysiology of addictive behaviors in PD, modulating the severity of symptoms and the rate of remission at follow-up. If confirmed in larger independent cohorts, TPH2 genotype may become a useful biomarker for the identification of at-risk individuals.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Roberto Cilia, Roberta Benfante, Rosanna Asselta, Laura Marabini, Emanuele Cereda, Chiara Siri, Gianni Pezzoli, Stefano Goldwurm, Diego Fornasari,